Related Experiment Videos
LHRH analogues in early breast cancer
1University Hospital, Hamburg, FRG.
Hormone Research
|January 1, 1989
Abstract:
A steering group has devised a protocol to compare relapse-free survival rates between women under 50 with stage II cancer, given CMF or Zoladex as adjuvant therapy. The design of the trial is discussed.